GlycoMimetics Inc

FRA:GKO (USA)  
€ 2.87 (+0.53%) Mar 28
At Loss
P/B:
4.39
Market Cap:
€ 179.86M ($ 193.81M)
Enterprise V:
€ 135.10M ($ 145.58M)
Volume:
-
Avg Vol (2M):
2.45K
Also Trade In:

Business Description

Description
GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.
Name Current Vs Industry Vs History
Cash-To-Debt 48.82
Equity-to-Asset 0.88
Debt-to-Equity 0.02
Debt-to-EBITDA -0.03
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 70.9
9-Day RSI 63.99
14-Day RSI 59.22
6-1 Month Momentum % 98.2
12-1 Month Momentum % 114.23

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 8.14
Quick Ratio 8.14
Cash Ratio 7.73

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -7.8
Shareholder Yield % -13.82
Name Current Vs Industry Vs History
FCF Margin % -46342.25
ROE % -74.76
ROA % -65.24
ROIC % -1441.18
ROC (Joel Greenblatt) % -3719.73
ROCE % -78.91

Financials

FRA:GKO's 30-Y Financials
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

GlycoMimetics Inc Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 0.071
EPS (TTM) (€) -0.589
Beta 2.03
Volatility % 88.13
14-Day RSI 59.22
14-Day ATR (€) 0.09724
20-Day SMA (€) 2.591
12-1 Month Momentum % 114.23
52-Week Range (€) 1.04 - 3.185
Shares Outstanding (Mil) 64.39

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 2
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

GlycoMimetics Inc Filings

Filing Date Document Date Form
No Filing Data

GlycoMimetics Inc Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

GlycoMimetics Inc Frequently Asked Questions

What is GlycoMimetics Inc(FRA:GKO)'s stock price today?
The current price of FRA:GKO is €2.87. The 52 week high of FRA:GKO is €3.19 and 52 week low is €1.04.
When is next earnings date of GlycoMimetics Inc(FRA:GKO)?
The next earnings date of GlycoMimetics Inc(FRA:GKO) is .
Does GlycoMimetics Inc(FRA:GKO) pay dividends? If so, how much?
GlycoMimetics Inc(FRA:GKO) does not pay dividend.

Press Release

Subject Date
No Press Release